Mode
Text Size
Log in / Sign up

Digital behavioral weight loss interventions significantly reduce BMI and waist circumference in breast cancer survivorsDigital weight loss programs help breast cancer survivors lose weight

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider digital behavioral weight loss interventions to reduce BMI and waist circumference in breast cancer survivors.

This meta-analysis evaluated the impact of digital behavioral weight loss interventions on several physical and lifestyle outcomes among breast cancer survivors (n=4644). The analysis synthesized data from randomized controlled trials to determine the efficacy of digital platforms in managing weight and activity levels.

Key findings indicate that participants using these interventions experienced a significant reduction in body weight (MD = -2.41; 95% CI: -3.32 to -1.49, P < 0.001) and BMI (MD = -0.94; 95% CI: -1.51 to -0.37, P = 0.001). Additionally, waist circumference was significantly reduced (MD = -3.06; 95% CI: -4.20 to -1.93, P < 0.001), and physical activity levels showed a significant increase (SMD = 0.53; 95% CI: 0.42 to 0.65, P < 0.001). However, improvements in quality of life were not statistically significant (P > 0.05).

The authors note a critical need for standardized frameworks for digital weight-loss interventions to improve consistency and outcomes. Clinically, these interventions may serve as an effective tool for improving physical metrics and activity levels in breast cancer survivors, though their impact on subjective quality of life remains uncertain.

How this fits prior evidence

This meta-analysis addresses a gap in managing the physical health of breast cancer survivors by evaluating digital behavioral weight loss interventions. While previous evidence confirmed that exercise improves sleep in breast cancer survivors via an inverted U-shaped dose-response, this study specifically highlights the efficacy of digital tools for reducing BMI and waist circumference. The findings provide a specific method to improve physical activity (SMD = 0.53) in this population.

Living with the effects of breast cancer is a long journey, and managing weight can be a significant part of that process. A large review of clinical trials involving over 4,600 survivors found that digital behavioral interventions can help patients reach their goals. These programs focus on behavior changes to manage body weight and lifestyle.

The data showed that participants using these digital tools saw a significant drop in body weight and waist circumference. They also saw a decrease in their BMI (body mass index) and an increase in their physical activity levels. While the program helped with physical metrics, it did not show a statistically significant change in overall quality of life scores.

While these results are promising for survivors looking for accessible ways to stay active, the research notes that more standardized frameworks are needed for these digital programs. Because every person's health journey is unique, talk to your doctor about how these types of digital tools might fit into your specific recovery plan.

What this means for you:
Digital weight loss programs can help breast cancer survivors lower their BMI and increase physical activity.

Common questions

Can digital programs actually help me lose weight after breast cancer?

Yes, the data shows that digital behavioral weight loss interventions significantly reduced body weight and waist circumference in survivors. These programs also helped participants lower their BMI and increase their physical activity levels.

Will these programs improve my overall quality of life?

While the study showed significant improvements in physical metrics like weight and activity, it did not find a statistically significant change in quality of life scores. You should speak with your doctor about what matters most for your personal well-being.

How many people were included in this research?

The study analyzed data from 4,644 breast cancer survivors who participated in various trials to see how digital weight loss interventions affected their health and activity levels.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
OBJECTIVE: This study aims to systematically evaluate the effectiveness of digital behavioural weight-loss interventions on body weight, BMI, waist circumference, physical activity, and quality of life in breast cancer survivors. METHODS: A comprehensive search was conducted across six databases, including PubMed, Scopus, Embase, Web of Science, CINAHL, and Cochrane Library, to identify eligible randomised controlled trials that investigated the effectiveness of digital behavioural weight loss interventions in weight management among breast cancer survivors. Data synthesis was performed using Stata 18.0 and Review Manager 5.4.1, and the quality of evidence was assessed using the GRADE system. RESULTS: A total of 17 RCTs involving 4644 breast cancer survivors who met the inclusion criteria were included. The meta-analysis results showed that digital weight loss interventions significantly reduced body weight (MD = -2.41, 95% CI: -3.32 to -1.49, P < 0.001), BMI (MD = -0.94, 95% CI: -1.51 to -0.37, P = 0.001) and waist circumference (MD = -3.06, 95% CI: -4.20 to -1.93, P < 0.001), and significantly increased levels of physical activity (SMD = 0.53, 95% CI: 0.42 to 0.65, P < 0.001). The improvement in quality of life was not statistically significant (P > 0.05). CONCLUSION: Digital behavioural weight loss interventions can effectively improve weight, BMI, waist circumference, and physical activity levels in breast cancer survivors, and thus hold significant clinical value. Future research should further explore standardised frameworks for digital weight-loss interventions and examine their impact on quality of life. TRIAL REGISTRATION: PROSPERO CRD420261304996; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261304996.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.